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.../..Lor almost two years, horse antihuman-
lymphocyte globulin (ALG) has been ad-
ministcrcd intramuscularly to patients in our 
institutions as an adjuvant immunosuppres-
siyDE~ agent after homotransplantation of kid-
neys and livers. For 1110st of this period, the 
Al.G was prepared by precipitation with am-
monium sulfate according to thc mcthods 
dl'sl'I'ibcd by I wasa.ki and co-wol'kcl's.4 The 
evideIlce is strongn•12 that therc was a re-
sulting improvemcnt in patient care. How-
ever, a numbcr of annoying or alanning 
toxic manifcstations were observed.5 , 12 These 
included intcnse pain at the injection site, 
fcver, thrombocytopenia, skin rashes, the 
dc\-c!opment of antibodies against the equine 
protein, and anaphylactic reactions. 
From the beginning, there was reason to 
believe that at least some of the side reac-
tions could be minimized by improving the 
ALG. For example, one possibility was that 
the local pain was an Arthus reaction, since 
the ALG contained antibodies against sev-
eral human plasma proteins, particularly 
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fibrinogen. The variable presence of anti-
pla:elet antibodies could explain the throm-
bocytopenia. The precipitating antibodies 
developed by the patients after weeks or 
months of therapy were directed principally 
against the small amounts of alpha and beta 
globulins contained in the ALGa; rarely were 
thcre detectable preclplhns against the 
gamma·G globulin which is thought to be 
thc active constituent of ALG. 
This report will' describe efforts to im-
prove the quality of antilymphocyte globu-
lin. These first involved changing the 
techniques for preliminary absorption of the 
raw serum. In addition, a batch technique 
was developed for the extraction on a 
mass-production basis of pure antilympho-
cyte gamma-G globulin (ALGG). The re-
sulting product was tested in canine 
recipients of renal homografts to be sure 
that it had not lost its immunosuppressive 
efficacy in the process of refinement. Finally, 
a comparable antihuman ALGG was used 
clinically. 
METHODS 
Modificatiom of absorption. Certain de-
tails of absorption were changed from the 
technique originally described by Iwasaki 
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BEFORE ABSORPTION 
"~""-"DDDDDDK--DII--»D~_DDD_D _>I::~ -ANTIHUMAN SERUM (TROUGH) D~-:;K>m _~~~D~~~ "", _ HUMAN PLASMA (WELL> 
',' -RAW ALS (TROUGH) 
"I~ -HUMAN SERUM (WELL) 
AFTER ABSORPTION 
K-K~KI>I -;:-:::::::; >~"KI;:=:=:: -ANTIHUMAN SERUM (TROUGH) II~K~ c',' ",", -',," _ HUMAN PLASMA (WELL) 
-",>ABSORBED ALS (TROUGH) 
- HUMAN SERUM (WELL) 
Fig. 1. Immunoelectrophoresis of immune horse serum (ALS) before and after absorption with 
human plasma (1 part to 10 parts horse serum), red cells, and thrombocytes. Above: Before 
absorption, Note the precipitin lines against most of the human plasma protein fractions in-
cluding fibrinogen (arrow). Below: After absorption. All precipitin lines have disappeared 
except for a faint one in the alpha2 region, 
and associates. 4 Previously, the raw horse 
s('rum was first decomplemented by heating 
to 560 C., then absorbed against human red 
cells, and finally absorbed against pooled 
human serum. The decomplementation was 
d()ne first, in order to avoid hemolysis of the 
added human red cells. The procedure had 
two flaws: (1) The use of serum for absorp-
tion precluded the removal of antifibrinogen 
(Fig. I) and anti thrombocyte antibodies. (2) 
The precipitation of equine antibodies di-
rected against other human plasma proteins 
(Fig. 1) was made inefficient by the absence 
of complement at this stage. 
1 : 10 proportion was rou tincly used in order 
to prevent excess dilution of the ALS. 
Before incubation, the human platelets 
isolated earlier were added to the mixture 
in quantities determined by the premeasured 
level of the anti platelet activity in the ALS. 
In a given laboratory, an estimate of the 
number of platelets needed can be obtained 
by establishing standards such as shown in 
Table 1. The addition of even very large 
volumes of platelet packs did not materially 
reduce the antileukocyte titer in the even-
tual supernatant fluid (Table I). 
After centrifugation for 15 minutes at 
10,000 r.p.m., the supernatant fluid was 
heated at 56° C. for 30 minutes. Absorption 
as previously described4 was now carried out 
with the human red cells. Hemolysis did not 
occur. At the completion of the various ab-
I sorption procedures, the total protein con-
tent of the horse serum had decreased by 15-
III 20 1lf'ITt>IIL . 
These objections were eliminated by the' 
following procedure. Whole blood was col-
lected from multiple donors." EDT A was 
used as an anticoagulant to prevent platelet 
ag-gregalion. The red cells, plasma, and 
platelet~ were then separated with differen-
tial c(·lltrirligatioll. The human plasma was 
;,<1<1,,<1 ,,, ti", 1I11:t!tt'I'('d florsf~ St'l'Ill1l. silrillll~ 
yDEFllffle~ ratios w,'re wsled arl!~fD itll'1I1,al;oll 
for 2 holll's at :no C, and 18 hours at 4° C. 
With the addition of one part of human 
I plasllla to two parts of horse serum, all of the 
I'lrpllI'ltlltjll of glUlllllil-f i ~lff""fiflI '1111' 
optimum conditioll!! for elTicielll batrh Illix-
ing were determined by trial and error, with 
the use of crude ALS, DEAE-cellulose* was 
added to the horse senlm in amounts far in I, E~fglfine precipitating antibodies were clim-.' illateli, A t a ratio of 1: 10 the removal was 
not, quite (;omplete (Fig. 1). However, the *Cclle,,-D. exchange capacity 0.8 mEq. pcr Ilram, Bio· Rad Laboratories, Richmond, Cali I. 
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Table 1. Absol'jltion of thromboagglutinins 
in 111«' allli/lllllUl/L ALS with 
hUlllan Jilatclcts 
.Vo. of Throm-
lilalclets boagglu- Leukoag- Lympho-
added to 2 tinill glutinin cytotoxin 
mi. of ALS titer titer titer 
Control 1 :48 1: 2,000 1: 36,000 
1.9 x 107 1 :48 
3.8 x 107 1 :48 
7.5 x 107 1:24 1: 2,000 1: 18,000 
1.5 x 108 1:12 
3.0 x 108 1 :6 1: 2,000 1: 18,000 
6.0 x 108 1 :6 
1.2 x 109 1:3 1: 1,000 1: 18,000 
2.4 x 109 1: 3 
4.8 x 109 0 1: 2,000 1: 18,000 
excess of those calculated to be neccssary 
according to the protein content of the 
serum and the manufacturer's extraction 
assay of the DEAE; 1 Gm. of dry diethyl-
aminoethyl (DEAE)-cellulose (wet weight 
8 Gm.) was used per milliliter of ALS. 
The pH and molar concentration were 
controlled by the addition of 20 Ill!. of var· 
i<llls phosphate bufrers per milliliter of 
serulll. The mixture was stirred for 3 hours 
at 4° C. and centrifuged at 10,000 r.p.m. 
for 10 minutes. The supernatant fluid was 
removed and concentrated to the original 
serum volume by ultrafiltration. It was now 
tested for total protein content, protein frac· 
tions, and leukoagglutinin titers. The po· 
tency per weight of protein was related to 
that of the original ALS by the formula: 
Potency coefficient 
Titer ALG 
Protein concentration ALG 
Titer ALS 
Protein concentration ALS 
The most efficient extraction of pure ALG 
was with a pH of 7.0 and a molarity of 
0.01 (Table II). 
The large quantities of DEAE-cellulose 
used per unit of serum in the foregoing pro· 
cess made it an impractical means for mass 
production. Changes were made to rectify 
this deficiency. First, crude globulin was re-
moved from the absorbed horse sennn as a 
preliminary' step, with the use of a single 
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precipitation with 0.4 saturation ammonium 
sulfate. 4 The precipitate was dissolved in 
normal saline to half the volume of the 
absorbed serum and dialyzed with tap water 
to remove excess ammonium sulfate. The 
resulting product, which was now ready for 
the additional batch extraction, is shown in 
Fig. 2. It contained alpha, beta, and gamma 
globulin and a trace of albumin. 
Next, each milliliter of raw globulin solu-
tion was mixed with 0.4 Gm. of DEAE-
cellulose instead of 1 Gm. This adjustment 
necessitated another change, since it could 
be shown by column chromatography that 
the large volumes of sodium phosphate buf-
fer now eventually permitted the washing 
through of significant quantities of beta 
globulin. When the quantity of buffer added 
to the batch was reduced to 2.4 ml. per 
milliliter of globulin solution, the superna-
tant fluid again contained pure gamma-G 
globulin. 
This supernatant fluid was dialyzed 
against normal saline to insure isotonicity, 
concentrated with ultrafiltration to the 
original volume of the raw globulin solution, 
sterilized by passage through a Millipol'c 
filter, and stored in sterile bottles. It had a 
pH of 7.01 to 7.08. 
Immunologic testing. The protein concen-
tration was determined of the crude serum, 
intermediate product!t, and the final globu-
lin. The constituents were identified with 
cellulose acetate electrophoresis and immu-
noelectrophoresis. A profile of the specific 
activity of the ALS or its by-products was 
obtained by measuring the titers of leukoag-
glutinins,2 lymphocytotoxins,13 and antiplate-
let antibodies.s Hemagglutinins and hemoly-
sins were determined with twofold antibody 
dilution. The precipitins were first studied 
with a standard ring test with the use of 
• twofold antigen dilution. The specific canine 
Or human plasma proteins against which the 
precipitins reacted were then identified by 
immunoelectrophoresis. 
The final antihuman ALGG was com-
pared with ammonium sulfate-precipitated 
ALG prepared from the same absorbed 
serum in an additional way. Both were sub-
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IMMUNOELECTROPHORESIS 
RAW ALS 
I I I I 
: i I I 
AFTER SINGLE 
PRECIPITATION 
f~InKK~ WITH !_~ .• __ ._ -D:D=:::p~;;jiiilleKD:";"i!e-K!l!!!:==:::~ .• ,_ 0.4 SAT. (NH4)zS04 
I I 
I I 
1/j\ 
• + + + 
AFTER SUBSEQUENT 
DEAE - CELLULOSE 
ALBUMIN a f3 y EXTRACTION Ir ... ·r~~D-~-K ,.,' ~IK 41 ;:;. 
Fig. 2. Electrophoretic and immunoelectrophoretic patterns of unabsorbed antihuman ALS, the 
raw globulin obtained with a single ammonium sulfate precipitation of absorbed ALS, and the 
final product (pure gamma-G globulin) after subsequent DEAE-cellulose batch extraction. 
jected to immunoelectrophoresis against the 
serum from a patient who had been sensi-
tized against horse protein. By so doing, it 
was possible to determine which antigens in 
these two products would react with this 
particular patient's serum. 
Testing in animals. Several batches of 
ALGG were tested for pyrogenicity by intra-
venously injecting rabbits with 50 mg. per 
kilogram. Fever was not observed. LD50 
experiments in mice were not pursued when 
it was found that no deaths occurred even 
when intraperitoneal doses as great as 1 mg. 
per gram did not cause death. 
The immunosuppressive efficacy of the 
canine ALGG was assessed after pelvic renal 
homotransplantation to 11 recipients sub-
jected to concomitant bilateral nephrectomy. 
Nonrelated mongrel donors were used. The 
ALGG was started two days before opera-
tion and continued daily thereafter for at 
least one month postoperatively in animals 
that lived this long. The individual subcu-
taneous doses were 0.125 ml. per kilogram 
of an injectate that had a protein concentra-
tion of 3.3 to 3.9 Gm. percent and a leukoag-
glutinin titer of 1 :4,000. The survival was 
compared to that of 10 unaltered control 
animals. At autopsy the homografts were 
I fixed in 10 percent formalin for studies with 
light microscopy. 
Clinical trials. After the appropriate ani-
mal experimentation had been completed, 
human ALGG was given to patients in a 
regimen comparable to that described in 
previous reports on ALG.ll, 12 It was used as 
an adjuvant to therapy with azathioprine 
and prednisone in five recipients of kidney 
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Table II. The effect of pH and molar concentration of sodium phosphate buffer 
in the DEAE-cellulose mix on the quantity and characteristics of the protein 
il1 the supematant. The highest yield of pure gamma-G globulin was with pH 7.0 
and molarity 0.01 
Globulin frac-
tions found with 
Protein content Leukoagglutinin Potency immunoelectro-
pH 
Raw ALS 
Molarity (Gm. %) titer coefficient* phoresis 
----~--------~--~----~--~-----8.20 1: 8,000 1.00 
Supernatant fluid 
after DEAE-
cellulose 
extraction 
7.5 
7.5 
7.0 
7.0 
6.3 
6.3 
*Ddillrd ill Ihe text • 
0.005 
0.01 
0.005 
O.ot 
0.005 
0.01 
0.8 8 
1.2 9 
1.4 3 
1.9 6 
2.2 0 
2.7 0 
. or liver hOlllografls. The brid [ollow-Ilp pre-
dlldes a 1IH';\nillgful evaluation of the iUlJl1u-
nosuppressive clrcet. However, the toxicity 
was studied by the same clinical and sero-
logic criteria which were applied to the pre-
viously used ALG.5 Principal emphasis was 
upon the clinical findings of pain, fever, and 
anaphylactic reactions and upon the inunu-
nologic data provided by skin testing and 
serologic measurements of the recipient's 
serum. 
RESULTS 
In vitro features of the human ALGG. 
The final product was pure gamma-G glob-
ulin (Fig. 2) with a protein concentration 
of 3.2 to 3.5 Gm. percent, a leukoagglutinin 
titer of 1 : 2,000 to 1 : 4,000, and a lymphocyto-
toxicity titer of 1:18,000 to 1:36,000 (Table 
111).* The loss of ganuna-G globulin in the 
total process was approximately one half. 
Absorption and ammonium sulfate precipi-
tation accollnled [or most of this loss since 
'/0 1'1'1'('1'111 and r,;) I'I'ITC'III, n~spl:I·ItislDlyI 1'11-
mained after the two initial steps. After the 
final batch treatment, approximately 53 per-
cent could still be recovered. 
*The di.paricy between the leukoagglutinin and lymphocy-
totoxin titers reflects. principally difCercDCel in the -7 
in which the tests are performed. 
1: 2,000 2.36 'YG 
1 :4,000 3.18 'YG 
1 :4,000 2.87 'YG 
1: 8,000 4.12 'YG 
1 :8,000 3.78 'YG, 'YA, I'M, fJ 
1 :8,000 3.04 'YG, 'YA, I'M, fJ 
The pOlency coefficient o[ the ALGG as 
dl'fillcd ('arlier was much greatel' than that 
of ALG produced from the same serum with 
previously employed techniques,' since an 
equivalent anti-white-cell activity was pres-
ent in the ALGG in spite of a much-reduced 
protein concentration (Table III). In both 
the ALG and ALGG, the effectiveness of the 
improved absorption techniques was re-
Hected in the low titers of antired cell, anti-
thrombocyte, and precipitating antibodies 
(Table III). The 'lack of specific activity 
against human plasma proteins was particu-
larly well demonstrated with inununoelectro-
phoresis (Fig. 1). 
When ALGG was tested with immuno-
electrophoresis against the serum of a 
patient sensitized against horse protein, there 
were no precipitin lines. In contrast, the 
sensitized patient's serum reacted with the 
~eta globulin in the ammonium sulfate-pre-
pared ALG. 
Immunosuppressive effect of ALGG in 
dEF~sK With lmrvival clDf~dit {or individllal 
dogs limited to 50 days, the 11 redpil'nts 
treated with. ALGG had a mean survival of 
23.2 ± 15.7 (S.D.) days as compared with 
1~K4 ± 7.8 in 10 untreated controls (p<0.05). 
Of the treated dogs, 5, 4, 3, and 2 lived for 
more than 15, 20, 30, and 50 days, respec-
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Table III. Com/laratioe chemical and immunologic data on ALeC jlToduced with 
DHAH--alllllosc batch technique and ALe Jlrepared with double ammonium 
sulfate jll"l'cijJitatio1!s from the same ralU ALS 
Total protein (Gm. %) 
A /lti·TV IlG activity 
L(,ukoagglutinin titer 
Potency cocfficicnt* 
Lymphocytotoxin titer 
Potency coefficient* 
Purity 
Immunoelectrophoresis 
Electrophoresis 
Anti·RBC activity 
Hemoagglutinin titer 
Hemolysin titer 
Antiplatelet activity 
Thromboagglutinin titer 
Antiplasma protein activity 
Precipitin titer 
*Defined in text. 
AI,s 
9.6 
1 :4,000 
1.00 
1: 18,000 
. 1.00 
1: 2,000 
1: 16 
1 :48 
1: 2,560 
tively. Of the control dogs, all but one died 
in less than 15 days, the exceptional animal 
living for 35 days. Postmortem examination 
of the homografts in both the treated and 
control animals showed typical features of 
rejection, although this was less advanced in 
the former series. 
Clinical trials. The 5 patients had pain at 
the illt ramusculal' illjection sites. This was 
silllilar to that caused by the previously lIsed 
crude ALG. Occasional low fevers also 
seemed related to the injections of ALGG, 
but with a much-reduced frequency com-
pared to the old ALG. Although the globu-
lin had a low antiplatelet titer, transient 
thrombocytopenia was seen in 2 cases. 
During the 6 weeks of therapy, no pre-
cipitin antibody response has occurred. 
During the same time, more than 90 percent 
of patients treated in the past with ammo-
nium sulfate-precipitated ALG exhibited 
increases in precipitins.6 However, all 5 pa-
tients have had increases in hemagglutinin 
titers, to a maximum of 1:8 to 1 :32. No 
anaphylactic reactions or generalized skin 
rashes have thus far been seen. 
ALe ALec 
7.4 3.6 
1 :4,000 1 :4,000 
1.30 2.67 
1: 36,000 1: 36,000 
2.59 5.34 
a, p, 'Y yG 
a, p, 'Y Y 
1 :64 1 :64 
0 0 
1 :3 1 :3 
1 :40 1 :40 
DISCUSSION 
The results in this study have shown that 
a high-quality garnma-G globulin (ALGG) 
can be produced with a batch technique 
from the serum of immunized horses. The 
loss rate of the desired antibody was no 
greater and it was probably less than when 
multiple ammonium sulfate precipitations 
were used as the sole I\Jcam of ext I'acting 
the globulin. When tested as an iIlIlIlIlIlOSIlP-
pressive agent in dogs, the ALGG had ap-
proximately the same ability to prevent or 
delay homograft rejection as was previously 
reported from this laboratoryl1 for unrefined 
ALS or ammonium sulfate-precipitated 
ALG. 
The primary theoretical advantage of 
batch techniques is that large quantities of a 
pure proteil1 fraction should be producible 
with less extensive equipment than is needed 
for column extraction. Both methods all~ 
based upon the same chemical principle-
The feasibility of batch methods was demoli' 
strated by Stanworth8 in 1960, also usill': 
DEAE-cellulose, and later by Sgouris and 
co-workers. T DEAE-Sephadex haS been used 
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for the same purpose by Baumstark and 
co-workers, l and tested for the preparation 
of ALG by Perper and co-workers.6 In all of 
these reports, except that of Perper and his 
associates, the amounts of gamma-G globu-
lin produced per volume of mix were very 
small. With the technique described in the 
present study, the objection was overcome 
by a first-step ammonium sulfate precipita-
tion and by the appropriate manipulation of 
the amounts of DEAE-cellulose and phos-
phate buffcrs. 
In dogs, the ALGG produced by this 
method had an immunosupprcssivc cffect 
which was neither bctter nor worse than 
that of less pure ALS or ALG prcparations; 
thc same is probably true for thc globulin 
produced for clinical use. Whether IHunan 
ALGG proves to havc striking advantages 
OWl' the previously used ALG remains to bc 
seen. In spitc of the improved absorption 
proccdures, thc high degrcc of purification, 
and thc reduced protein contcnt, thc injec-
lion of ALGG was still painful and in some 
cascs seemcd to cause thrombocytopenia. 
Aftcr several weeks of administration, there 
were rises in hemagglutinin titers which in-
dicated a response to Forssman antigen 
which is present in horse but not human 
protein. Howcvcr, thc precipitin response 
St'\'n in past cascs and directed primarily 
Iy~Iy::yIt .lll'ha and bela glohulins, in am-
:",.':::lllll S\lliah' precipitatcd ALG, was clim-
.... 1.',1 wilh thc lise of ALGG. Thus, it is 
Ik."ihl.· that the chief bcnefit of ALGG will 
Ill" in a l'l'dllction in the incidcnce of dc-
1.\\('l! wlIlplications of foreign protein ther-
; ., ",j':- J.'; .1:l.1?!.ylaxis. To date, anaphylac-
" ~!K":I:I::I :.:. .... e not been seen with the re-
'"' ... :: .. 
" '::.. tllphncyte gamma-G g lob u 1 i n 
. .1. ',. ;l~ produccd from the serum of 
KI~ horses. Modifications of the pre-
..lb·" Irption techniques permitted 
. 'I; "f :;;-;r!<;~i: .. ble, extraneous anti-
, '1.: "I~ "',(: oi a batch technique, 
~-.. f; ~~:DFbulin could then be re-
,-:·untities. The resulting 
ti_ t 4t4A1 up . 
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product was first confirmed to have immu-
nosuppressive qualities in dogs and then 
given a clinical trial. In patients, its admin-
istration occasionally caused low-grade fever 
and thrombocytopenia. Pain at the injection 
site was not eliminated. Precipitin antibody 
responses have apparently been prevented in 
the patients but not a host response to Forss-
man antigens. 
We wish to thank Thomas Wetherly, B.A., and 
Yoshiaki Arai, M,S" for excellent technical as-
sistance. 
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ADDENDUM 
ALGG was given to a total of 13 recipients of 
intrafamilial renal homografts. The results ob-
tained in these patients, sandwiched in between 
thc more extensive trials with the ammonium 
sulfate-precipitated ALG, were distinctly disap-
pointing. Although there were no anaphylactic 
rractions and few other side effects, the immuno-
supprrssi\'e potency appeared to have been greatly 
reduced by the pl'oerss of refinement. There were 
a greater number of severe rejections in the 13 
ALGG-treated patients than in the 72 cases in 
which the crude globulin had been used (Table 
IV). 
~ . 
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Table IV. Postoperative morbidity and 
mortality rate in 13 patients treated with 
ALGa. prepared by the DEAE-cellulose batch 
technique and in 72 patients receiving 
ammonium sulfate-precipitated ALG 
Series 
ALGG 
ALG 
I BUN Post- I No of (J 50 operative c~es mg. %) dialysis Deaths 
13 5 4 6 
72* 3 1 3 
*Fifty-eight of these cases were before the ALGG trial; 
14 were aCter. 
A probable explanation for this finding has 
recently been published.sB In horses subjected to 
long-term immunization, there is apparently a 
variable shift of the desired antibodies into the 
T-equine fraction, which is largely eliminated by 
the purification technique described in the pres-
ent communication. This apparently hacl not yet 
occurred in horses used for the canine test system, 
but had evidently done so in the chronically im-
munized horses which provided the antihuman 
ALS. Consequently, we have returned to the use 
of the less pure ammonium sulfate-precipitated 
ALG in subsequent clinical cases. 
In the rabbit and goat, there appears to be 
less tendency for migration of the active immuno-
globulin portion. Thus, the batch technique may 
prove to be more valuable and rrliable in these 2 
species. 
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